Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.90694158 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.90694158 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.61842261 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.61842261 |
5 | epoxygenase P450 pathway (GO:0019373) | 6.41064979 |
6 | exogenous drug catabolic process (GO:0042738) | 6.24786838 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 6.07990641 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.56744879 |
9 | kynurenine metabolic process (GO:0070189) | 5.40891100 |
10 | tryptophan catabolic process (GO:0006569) | 5.39808502 |
11 | indole-containing compound catabolic process (GO:0042436) | 5.39808502 |
12 | indolalkylamine catabolic process (GO:0046218) | 5.39808502 |
13 | omega-hydroxylase P450 pathway (GO:0097267) | 5.27204079 |
14 | bile acid biosynthetic process (GO:0006699) | 5.24176289 |
15 | glyoxylate metabolic process (GO:0046487) | 5.22150117 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.14842878 |
17 | actin-myosin filament sliding (GO:0033275) | 5.14735262 |
18 | muscle filament sliding (GO:0030049) | 5.14735262 |
19 | tryptophan metabolic process (GO:0006568) | 5.11842148 |
20 | cysteine metabolic process (GO:0006534) | 5.09482081 |
21 | sulfur amino acid catabolic process (GO:0000098) | 5.05498046 |
22 | complement activation, alternative pathway (GO:0006957) | 4.97622349 |
23 | urea cycle (GO:0000050) | 4.97445846 |
24 | urea metabolic process (GO:0019627) | 4.97445846 |
25 | skeletal muscle contraction (GO:0003009) | 4.95571043 |
26 | lysine metabolic process (GO:0006553) | 4.89937969 |
27 | lysine catabolic process (GO:0006554) | 4.89937969 |
28 | ethanol metabolic process (GO:0006067) | 4.81098631 |
29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.73983005 |
30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.72921052 |
31 | homocysteine metabolic process (GO:0050667) | 4.72090403 |
32 | serine family amino acid catabolic process (GO:0009071) | 4.70120414 |
33 | protein carboxylation (GO:0018214) | 4.67639443 |
34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.67639443 |
35 | regulation of protein activation cascade (GO:2000257) | 4.59645093 |
36 | nitrogen cycle metabolic process (GO:0071941) | 4.57218513 |
37 | bile acid metabolic process (GO:0008206) | 4.55354447 |
38 | negative regulation of fibrinolysis (GO:0051918) | 4.54553319 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.52336920 |
40 | amino-acid betaine metabolic process (GO:0006577) | 4.50435656 |
41 | drug metabolic process (GO:0017144) | 4.44382198 |
42 | regulation of skeletal muscle contraction (GO:0014819) | 4.41639466 |
43 | aromatic amino acid family metabolic process (GO:0009072) | 4.39571308 |
44 | regulation of fibrinolysis (GO:0051917) | 4.39155112 |
45 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.38713211 |
46 | cellular ketone body metabolic process (GO:0046950) | 4.38677740 |
47 | alpha-amino acid catabolic process (GO:1901606) | 4.36148911 |
48 | acylglycerol homeostasis (GO:0055090) | 4.34683407 |
49 | triglyceride homeostasis (GO:0070328) | 4.34683407 |
50 | regulation of complement activation (GO:0030449) | 4.31818898 |
51 | fructose metabolic process (GO:0006000) | 4.27417458 |
52 | actin-mediated cell contraction (GO:0070252) | 4.26176128 |
53 | tyrosine metabolic process (GO:0006570) | 4.23943238 |
54 | valine metabolic process (GO:0006573) | 4.21716798 |
55 | creatine metabolic process (GO:0006600) | 4.17055088 |
56 | negative regulation of cholesterol transport (GO:0032375) | 4.15611899 |
57 | negative regulation of sterol transport (GO:0032372) | 4.15611899 |
58 | reverse cholesterol transport (GO:0043691) | 4.14541824 |
59 | oxidative demethylation (GO:0070989) | 4.14419938 |
60 | short-chain fatty acid metabolic process (GO:0046459) | 4.14144453 |
61 | plasma lipoprotein particle remodeling (GO:0034369) | 4.12112939 |
62 | protein-lipid complex remodeling (GO:0034368) | 4.12112939 |
63 | macromolecular complex remodeling (GO:0034367) | 4.12112939 |
64 | phospholipid efflux (GO:0033700) | 4.11416848 |
65 | 2-oxoglutarate metabolic process (GO:0006103) | 4.11397981 |
66 | regulation of cholesterol esterification (GO:0010872) | 4.11202983 |
67 | cellular modified amino acid catabolic process (GO:0042219) | 4.10697365 |
68 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.08694629 |
69 | cellular glucuronidation (GO:0052695) | 4.06941656 |
70 | cellular amino acid catabolic process (GO:0009063) | 4.05394810 |
71 | regulation of cholesterol homeostasis (GO:2000188) | 4.03819260 |
72 | bile acid and bile salt transport (GO:0015721) | 4.00297877 |
73 | skeletal muscle adaptation (GO:0043501) | 3.99945416 |
74 | glutamate metabolic process (GO:0006536) | 3.99291498 |
75 | coenzyme catabolic process (GO:0009109) | 3.95352089 |
76 | ethanol oxidation (GO:0006069) | 3.93998674 |
77 | drug catabolic process (GO:0042737) | 3.91549342 |
78 | plasma lipoprotein particle assembly (GO:0034377) | 3.83511235 |
79 | fatty acid beta-oxidation (GO:0006635) | 3.83265359 |
80 | indolalkylamine metabolic process (GO:0006586) | 3.80702467 |
81 | plasma lipoprotein particle clearance (GO:0034381) | 3.79775167 |
82 | ketone body metabolic process (GO:1902224) | 3.79427337 |
83 | glycine metabolic process (GO:0006544) | 3.77091307 |
84 | NADH metabolic process (GO:0006734) | 3.77084548 |
85 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.74875095 |
86 | benzene-containing compound metabolic process (GO:0042537) | 3.74805743 |
87 | fatty acid oxidation (GO:0019395) | 3.73488714 |
88 | acetyl-CoA metabolic process (GO:0006084) | 3.73297534 |
89 | aspartate family amino acid catabolic process (GO:0009068) | 3.70924404 |
90 | serine family amino acid metabolic process (GO:0009069) | 3.70905685 |
91 | amino-acid betaine transport (GO:0015838) | 3.70325959 |
92 | carnitine transport (GO:0015879) | 3.70325959 |
93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70053746 |
94 | organic acid catabolic process (GO:0016054) | 3.67582520 |
95 | carboxylic acid catabolic process (GO:0046395) | 3.67582520 |
96 | monocarboxylic acid catabolic process (GO:0072329) | 3.65856304 |
97 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65770976 |
98 | lipid oxidation (GO:0034440) | 3.65546808 |
99 | amine catabolic process (GO:0009310) | 3.65095845 |
100 | cellular biogenic amine catabolic process (GO:0042402) | 3.65095845 |
101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63560744 |
102 | fatty acid catabolic process (GO:0009062) | 3.60683886 |
103 | phospholipid homeostasis (GO:0055091) | 3.58827809 |
104 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.57804586 |
105 | positive regulation of lipid catabolic process (GO:0050996) | 3.57257769 |
106 | cholesterol efflux (GO:0033344) | 3.55983225 |
107 | glucuronate metabolic process (GO:0019585) | 3.55785289 |
108 | uronic acid metabolic process (GO:0006063) | 3.55785289 |
109 | phenylpropanoid metabolic process (GO:0009698) | 3.55777607 |
110 | response to mercury ion (GO:0046689) | 3.54743086 |
111 | quaternary ammonium group transport (GO:0015697) | 3.53319545 |
112 | intestinal cholesterol absorption (GO:0030299) | 3.52137471 |
113 | drug transmembrane transport (GO:0006855) | 3.51847542 |
114 | imidazole-containing compound metabolic process (GO:0052803) | 3.50853764 |
115 | negative regulation of lipase activity (GO:0060192) | 3.49050539 |
116 | response to muscle activity (GO:0014850) | 3.48112530 |
117 | carnitine metabolic process (GO:0009437) | 3.47401871 |
118 | negative regulation of protein activation cascade (GO:2000258) | 3.45363306 |
119 | cholesterol homeostasis (GO:0042632) | 3.44076907 |
120 | protein-lipid complex assembly (GO:0065005) | 3.42676464 |
121 | arginine metabolic process (GO:0006525) | 3.42010441 |
122 | low-density lipoprotein particle remodeling (GO:0034374) | 3.41690658 |
123 | glycogen catabolic process (GO:0005980) | 3.41677831 |
124 | regulation of relaxation of muscle (GO:1901077) | 3.40083035 |
125 | glucan catabolic process (GO:0009251) | 3.38683415 |
126 | sterol homeostasis (GO:0055092) | 3.38598010 |
127 | macroautophagy (GO:0016236) | 3.37500984 |
128 | actin filament-based movement (GO:0030048) | 3.36124621 |
129 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.35885912 |
130 | flavonoid metabolic process (GO:0009812) | 3.35781618 |
131 | myofibril assembly (GO:0030239) | 3.34576154 |
132 | blood coagulation, intrinsic pathway (GO:0007597) | 3.31275473 |
133 | protein activation cascade (GO:0072376) | 3.27686049 |
134 | fibrinolysis (GO:0042730) | 3.26172009 |
135 | striated muscle contraction (GO:0006941) | 3.25900578 |
136 | carnitine shuttle (GO:0006853) | 3.24283383 |
137 | regulation of humoral immune response (GO:0002920) | 3.22867783 |
138 | oxaloacetate metabolic process (GO:0006107) | 3.21239925 |
139 | fatty acid transmembrane transport (GO:1902001) | 3.21204774 |
140 | negative regulation of complement activation (GO:0045916) | 3.16007972 |
141 | primary alcohol catabolic process (GO:0034310) | 3.14808098 |
142 | complement activation (GO:0006956) | 3.13634873 |
143 | complement activation, classical pathway (GO:0006958) | 3.12394332 |
144 | cellular polysaccharide catabolic process (GO:0044247) | 3.12257209 |
145 | carnitine transmembrane transport (GO:1902603) | 3.09299441 |
146 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08966142 |
147 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08966142 |
148 | negative regulation of humoral immune response (GO:0002921) | 3.08907974 |
149 | striated muscle atrophy (GO:0014891) | 3.02033661 |
150 | acute-phase response (GO:0006953) | 3.00242327 |
151 | alkaloid metabolic process (GO:0009820) | 2.96989209 |
152 | sarcomere organization (GO:0045214) | 2.85128385 |
153 | polysaccharide catabolic process (GO:0000272) | 2.83715332 |
154 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.78738318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.54181902 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.58313487 |
3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.97586468 |
4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.55566708 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.43738111 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.82538151 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.33876703 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74610676 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.17489074 |
10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.59768781 |
11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.18763659 |
12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.00967384 |
13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4691491 |
14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90837594 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85069072 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84731281 |
17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72777606 |
18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58768330 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53552504 |
20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49266627 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43336116 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40943477 |
23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39883671 |
24 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34293590 |
25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34032928 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29541666 |
27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29303166 |
28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25774906 |
29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24248835 |
30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22715928 |
31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22139354 |
32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.19846159 |
33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12476160 |
34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10671079 |
35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08495649 |
36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08177089 |
37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01713962 |
38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01238630 |
39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98913859 |
40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98908331 |
41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97658683 |
42 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.96611325 |
43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96274421 |
44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94127747 |
45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92548544 |
46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91637495 |
47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90856049 |
48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90271495 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90056279 |
50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89925145 |
51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88478664 |
52 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87984722 |
53 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87753978 |
54 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87132775 |
55 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86687511 |
56 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86687511 |
57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86175254 |
58 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85620113 |
59 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85011664 |
60 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84224986 |
61 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84053767 |
62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83670927 |
63 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83550902 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83087440 |
65 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82843207 |
66 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.82774720 |
67 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82636907 |
68 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.82509893 |
69 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81408612 |
70 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81282417 |
71 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80289547 |
72 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.80275993 |
73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79896484 |
74 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79833874 |
75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79711263 |
76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77490712 |
77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77420898 |
78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.77163348 |
79 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77099932 |
80 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76860782 |
81 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.76747908 |
82 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76687573 |
83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.75840100 |
84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75562573 |
85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75497042 |
86 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.75456126 |
87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75160657 |
88 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.74310478 |
89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74304064 |
90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73916636 |
91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73837186 |
92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73744412 |
93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.73369715 |
94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72990097 |
95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72835158 |
96 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72252014 |
97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72228411 |
98 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.71902514 |
99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71801291 |
100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71795112 |
101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.71656387 |
102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.71435252 |
103 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.70503245 |
104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70417032 |
105 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70245995 |
106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.70036683 |
107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69787131 |
108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69710060 |
109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.67378950 |
110 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67255864 |
111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64663783 |
112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63852150 |
113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62198016 |
114 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62099144 |
115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61945969 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61026165 |
117 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60717401 |
118 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.59611958 |
119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58652306 |
120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.58407402 |
121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.58219546 |
122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.57735585 |
123 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.57498292 |
124 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.57493267 |
125 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56411192 |
126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.55812272 |
127 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.55676066 |
128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.54325024 |
129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.54244907 |
130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.53563375 |
131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53345929 |
132 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.53333762 |
133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.52997083 |
134 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.52683248 |
135 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52602874 |
136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52531679 |
137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.51973754 |
138 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.51170234 |
139 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.50513751 |
140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.50065443 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.22169736 |
2 | MP0005360_urolithiasis | 6.77480022 |
3 | MP0005365_abnormal_bile_salt | 5.96761028 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.85400540 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.52665679 |
6 | MP0003252_abnormal_bile_duct | 4.07423678 |
7 | MP0004145_abnormal_muscle_electrophysio | 3.76150730 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.61352927 |
9 | MP0010329_abnormal_lipoprotein_level | 3.24855710 |
10 | MP0005083_abnormal_biliary_tract | 2.92244535 |
11 | MP0000751_myopathy | 2.80814216 |
12 | MP0001666_abnormal_nutrient_absorption | 2.80709451 |
13 | MP0003195_calcinosis | 2.72209093 |
14 | MP0009840_abnormal_foam_cell | 2.66963932 |
15 | MP0005332_abnormal_amino_acid | 2.62409713 |
16 | MP0000609_abnormal_liver_physiology | 2.18235993 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.06570914 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.06439174 |
19 | MP0002118_abnormal_lipid_homeostasis | 2.05582879 |
20 | MP0002106_abnormal_muscle_physiology | 1.92141579 |
21 | MP0003868_abnormal_feces_composition | 1.90813794 |
22 | MP0003191_abnormal_cellular_cholesterol | 1.84759764 |
23 | MP0004084_abnormal_cardiac_muscle | 1.84536662 |
24 | MP0002332_abnormal_exercise_endurance | 1.83012365 |
25 | MP0005319_abnormal_enzyme/_coenzyme | 1.75515058 |
26 | MP0004233_abnormal_muscle_weight | 1.73841810 |
27 | MP0003879_abnormal_hair_cell | 1.70205649 |
28 | MP0005369_muscle_phenotype | 1.61220036 |
29 | MP0000759_abnormal_skeletal_muscle | 1.57671312 |
30 | MP0001764_abnormal_homeostasis | 1.55773211 |
31 | MP0004130_abnormal_muscle_cell | 1.55417166 |
32 | MP0009780_abnormal_chondrocyte_physiolo | 1.54196797 |
33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51085151 |
34 | MP0009643_abnormal_urine_homeostasis | 1.50151114 |
35 | MP0002837_dystrophic_cardiac_calcinosis | 1.48063205 |
36 | MP0000013_abnormal_adipose_tissue | 1.45936969 |
37 | MP0005620_abnormal_muscle_contractility | 1.44827953 |
38 | MP0005451_abnormal_body_composition | 1.41341744 |
39 | MP0003705_abnormal_hypodermis_morpholog | 1.31016652 |
40 | MP0003300_gastrointestinal_ulcer | 1.29334774 |
41 | MP0004484_altered_response_of | 1.16045175 |
42 | MP0006036_abnormal_mitochondrial_physio | 1.14197777 |
43 | MP0002972_abnormal_cardiac_muscle | 1.14063826 |
44 | MP0003045_fibrosis | 1.10804770 |
45 | MP0001661_extended_life_span | 1.09111401 |
46 | MP0000598_abnormal_liver_morphology | 1.07988280 |
47 | MP0002078_abnormal_glucose_homeostasis | 1.06918974 |
48 | MP0005636_abnormal_mineral_homeostasis | 1.05992450 |
49 | MP0002822_catalepsy | 1.04406131 |
50 | MP0002971_abnormal_brown_adipose | 1.03965314 |
51 | MP0002108_abnormal_muscle_morphology | 1.03709051 |
52 | MP0005647_abnormal_sex_gland | 1.02764856 |
53 | MP0002168_other_aberrant_phenotype | 1.02281689 |
54 | MP0003186_abnormal_redox_activity | 0.99733876 |
55 | MP0005220_abnormal_exocrine_pancreas | 0.98761872 |
56 | MP0002254_reproductive_system_inflammat | 0.97268230 |
57 | MP0004510_myositis | 0.96585676 |
58 | MP0005670_abnormal_white_adipose | 0.94286210 |
59 | MP0009764_decreased_sensitivity_to | 0.93365195 |
60 | MP0004264_abnormal_extraembryonic_tissu | 0.93182205 |
61 | MP0000003_abnormal_adipose_tissue | 0.92965376 |
62 | MP0005666_abnormal_adipose_tissue | 0.92729550 |
63 | MP0010234_abnormal_vibrissa_follicle | 0.90915329 |
64 | MP0008872_abnormal_physiological_respon | 0.90745807 |
65 | MP0009697_abnormal_copulation | 0.90326181 |
66 | MP0005334_abnormal_fat_pad | 0.89433342 |
67 | MP0002166_altered_tumor_susceptibility | 0.88265980 |
68 | MP0005377_hearing/vestibular/ear_phenot | 0.88253588 |
69 | MP0003878_abnormal_ear_physiology | 0.88253588 |
70 | MP0000750_abnormal_muscle_regeneration | 0.87249092 |
71 | MP0009763_increased_sensitivity_to | 0.86778576 |
72 | MP0009642_abnormal_blood_homeostasis | 0.86763467 |
73 | MP0004947_skin_inflammation | 0.84093872 |
74 | * MP0008469_abnormal_protein_level | 0.83810641 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 0.83028136 |
76 | MP0004215_abnormal_myocardial_fiber | 0.82867713 |
77 | MP0002928_abnormal_bile_duct | 0.82216311 |
78 | MP0005535_abnormal_body_temperature | 0.81147255 |
79 | MP0003646_muscle_fatigue | 0.80194253 |
80 | MP0006138_congestive_heart_failure | 0.78215592 |
81 | MP0006035_abnormal_mitochondrial_morpho | 0.76868724 |
82 | MP0002796_impaired_skin_barrier | 0.76053481 |
83 | MP0001756_abnormal_urination | 0.74851970 |
84 | MP0004043_abnormal_pH_regulation | 0.73759562 |
85 | MP0009765_abnormal_xenobiotic_induced | 0.72136909 |
86 | MP0002127_abnormal_cardiovascular_syste | 0.71792586 |
87 | MP0001544_abnormal_cardiovascular_syste | 0.71142912 |
88 | MP0005385_cardiovascular_system_phenoty | 0.71142912 |
89 | MP0003011_delayed_dark_adaptation | 0.71087894 |
90 | MP0005448_abnormal_energy_balance | 0.70084599 |
91 | MP0002876_abnormal_thyroid_physiology | 0.69872371 |
92 | MP0004782_abnormal_surfactant_physiolog | 0.68657726 |
93 | MP0000733_abnormal_muscle_development | 0.68194009 |
94 | MP0008961_abnormal_basal_metabolism | 0.67702445 |
95 | MP0005376_homeostasis/metabolism_phenot | 0.67641402 |
96 | MP0001501_abnormal_sleep_pattern | 0.66194904 |
97 | MP0010630_abnormal_cardiac_muscle | 0.66156294 |
98 | MP0005166_decreased_susceptibility_to | 0.65968702 |
99 | * MP0010155_abnormal_intestine_physiology | 0.65549784 |
100 | MP0001984_abnormal_olfaction | 0.64301028 |
101 | MP0002269_muscular_atrophy | 0.64287685 |
102 | MP0005330_cardiomyopathy | 0.63354917 |
103 | MP0002136_abnormal_kidney_physiology | 0.63279002 |
104 | MP0010368_abnormal_lymphatic_system | 0.63094775 |
105 | MP0001881_abnormal_mammary_gland | 0.62488845 |
106 | MP0001765_abnormal_ion_homeostasis | 0.61195520 |
107 | MP0005266_abnormal_metabolism | 0.60539826 |
108 | MP0004185_abnormal_adipocyte_glucose | 0.59970357 |
109 | MP0000604_amyloidosis | 0.58638048 |
110 | MP0000249_abnormal_blood_vessel | 0.58362055 |
111 | MP0003866_abnormal_defecation | 0.57869849 |
112 | MP0005409_darkened_coat_color | 0.57557597 |
113 | MP0001243_abnormal_dermal_layer | 0.57317520 |
114 | MP0001944_abnormal_pancreas_morphology | 0.56829697 |
115 | MP0003436_decreased_susceptibility_to | 0.56602612 |
116 | MP0003959_abnormal_lean_body | 0.55335759 |
117 | MP0002060_abnormal_skin_morphology | 0.55062232 |
118 | MP0003724_increased_susceptibility_to | 0.55039859 |
119 | MP0004036_abnormal_muscle_relaxation | 0.54697634 |
120 | MP0005408_hypopigmentation | 0.54690599 |
121 | MP0002132_abnormal_respiratory_system | 0.52946140 |
122 | MP0000685_abnormal_immune_system | 0.52637991 |
123 | MP0005375_adipose_tissue_phenotype | 0.52408671 |
124 | MP0003638_abnormal_response/metabolism_ | 0.52008550 |
125 | MP0005084_abnormal_gallbladder_morpholo | 0.51427168 |
126 | MP0003953_abnormal_hormone_level | 0.51219605 |
127 | MP0000230_abnormal_systemic_arterial | 0.50813353 |
128 | MP0001849_ear_inflammation | 0.49300619 |
129 | MP0000747_muscle_weakness | 0.47375846 |
130 | * MP0001845_abnormal_inflammatory_respons | 0.46813314 |
131 | MP0000749_muscle_degeneration | 0.46405207 |
132 | MP0004087_abnormal_muscle_fiber | 0.45775655 |
133 | MP0002970_abnormal_white_adipose | 0.45496871 |
134 | MP0001853_heart_inflammation | 0.45435768 |
135 | MP0002933_joint_inflammation | 0.45021226 |
136 | MP0003453_abnormal_keratinocyte_physiol | 0.43425167 |
137 | MP0005464_abnormal_platelet_physiology | 0.43093907 |
138 | MP0009115_abnormal_fat_cell | 0.42308621 |
139 | MP0004381_abnormal_hair_follicle | 0.41962719 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 7.65061199 |
2 | Nemaline bodies (HP:0003798) | 7.51897159 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.25436867 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.37142834 |
5 | Intrahepatic cholestasis (HP:0001406) | 6.09061891 |
6 | Deep venous thrombosis (HP:0002625) | 6.02168886 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.64184901 |
8 | Xanthomatosis (HP:0000991) | 5.54568996 |
9 | Hypobetalipoproteinemia (HP:0003563) | 5.41551896 |
10 | Type 1 muscle fiber predominance (HP:0003803) | 5.33104776 |
11 | Prolonged partial thromboplastin time (HP:0003645) | 5.09305029 |
12 | Exercise-induced muscle cramps (HP:0003710) | 4.98895541 |
13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.59609601 |
14 | Hypoglycemic coma (HP:0001325) | 4.58767999 |
15 | Ketosis (HP:0001946) | 4.56062977 |
16 | Hyperlipoproteinemia (HP:0010980) | 4.53765517 |
17 | Hyperammonemia (HP:0001987) | 4.41621466 |
18 | Hyperglycinuria (HP:0003108) | 4.41528146 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.35596408 |
20 | Hypolipoproteinemia (HP:0010981) | 4.22991349 |
21 | Complement deficiency (HP:0004431) | 4.20890121 |
22 | Calf muscle hypertrophy (HP:0008981) | 4.13345933 |
23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.12917005 |
24 | Abnormality of glycine metabolism (HP:0010895) | 4.12917005 |
25 | Myopathic facies (HP:0002058) | 4.10566474 |
26 | Hyperglycinemia (HP:0002154) | 3.97731103 |
27 | Epidermoid cyst (HP:0200040) | 3.90507594 |
28 | Ketoacidosis (HP:0001993) | 3.88576007 |
29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.84693749 |
30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.83266018 |
31 | Hypoalphalipoproteinemia (HP:0003233) | 3.82823685 |
32 | Joint hemorrhage (HP:0005261) | 3.82728093 |
33 | EMG: myopathic abnormalities (HP:0003458) | 3.82017336 |
34 | Distal arthrogryposis (HP:0005684) | 3.81824981 |
35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.79016269 |
36 | Fat malabsorption (HP:0002630) | 3.67967994 |
37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.66671778 |
38 | Hyporeflexia of lower limbs (HP:0002600) | 3.56378440 |
39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.53730418 |
40 | Abnormality of methionine metabolism (HP:0010901) | 3.50324780 |
41 | Muscle fiber splitting (HP:0003555) | 3.45259623 |
42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33635308 |
43 | Round ear (HP:0100830) | 3.33342222 |
44 | Abnormality of the calf musculature (HP:0001430) | 3.26003180 |
45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.24386899 |
46 | Ulnar deviation of the wrist (HP:0003049) | 3.18544668 |
47 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.18262011 |
48 | Gout (HP:0001997) | 3.16745967 |
49 | Conjugated hyperbilirubinemia (HP:0002908) | 3.12058234 |
50 | Dicarboxylic aciduria (HP:0003215) | 3.10751891 |
51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.10751891 |
52 | Glomerulonephritis (HP:0000099) | 3.10274535 |
53 | Hyperkalemia (HP:0002153) | 3.07333982 |
54 | Hypercholesterolemia (HP:0003124) | 3.06788420 |
55 | Asymmetric septal hypertrophy (HP:0001670) | 3.04753186 |
56 | Abnormality of purine metabolism (HP:0004352) | 3.03575884 |
57 | Neck muscle weakness (HP:0000467) | 3.00566761 |
58 | Hypoplasia of the thymus (HP:0000778) | 2.98654750 |
59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98159753 |
60 | Abnormality of complement system (HP:0005339) | 2.95959182 |
61 | Hypoglycemic seizures (HP:0002173) | 2.91416916 |
62 | Hyperbilirubinemia (HP:0002904) | 2.90961215 |
63 | Metabolic acidosis (HP:0001942) | 2.90211266 |
64 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.87327493 |
65 | Distal lower limb muscle weakness (HP:0009053) | 2.86556885 |
66 | Myoglobinuria (HP:0002913) | 2.79799937 |
67 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.76554393 |
68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.75120488 |
69 | Rimmed vacuoles (HP:0003805) | 2.74462579 |
70 | Hydroxyprolinuria (HP:0003080) | 2.73120636 |
71 | Abnormality of proline metabolism (HP:0010907) | 2.73120636 |
72 | Myocardial infarction (HP:0001658) | 2.70236515 |
73 | Difficulty running (HP:0009046) | 2.69034079 |
74 | Abnormality of serum amino acid levels (HP:0003112) | 2.68821209 |
75 | Late onset (HP:0003584) | 2.66775234 |
76 | Steatorrhea (HP:0002570) | 2.66121603 |
77 | Sudden death (HP:0001699) | 2.64149424 |
78 | Generalized aminoaciduria (HP:0002909) | 2.61907631 |
79 | Bundle branch block (HP:0011710) | 2.61274213 |
80 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.59080099 |
81 | Subaortic stenosis (HP:0001682) | 2.59080099 |
82 | Skin nodule (HP:0200036) | 2.56611416 |
83 | Delayed CNS myelination (HP:0002188) | 2.51241438 |
84 | Lethargy (HP:0001254) | 2.48978601 |
85 | Hepatocellular carcinoma (HP:0001402) | 2.47852757 |
86 | Hyperglycemia (HP:0003074) | 2.45815816 |
87 | Frequent falls (HP:0002359) | 2.42154024 |
88 | Neonatal onset (HP:0003623) | 2.38003875 |
89 | Muscle stiffness (HP:0003552) | 2.37984241 |
90 | Pancreatitis (HP:0001733) | 2.37683224 |
91 | Malignant hyperthermia (HP:0002047) | 2.37418347 |
92 | Abnormal gallbladder morphology (HP:0012437) | 2.36120508 |
93 | Increased connective tissue (HP:0009025) | 2.34405717 |
94 | Vascular calcification (HP:0004934) | 2.32825998 |
95 | Hyperuricemia (HP:0002149) | 2.32409950 |
96 | Increased purine levels (HP:0004368) | 2.32409950 |
97 | Exercise-induced myalgia (HP:0003738) | 2.30403800 |
98 | Cholelithiasis (HP:0001081) | 2.28434803 |
99 | Cerebral edema (HP:0002181) | 2.26984865 |
100 | T lymphocytopenia (HP:0005403) | 2.23369644 |
101 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.23282296 |
102 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22094672 |
103 | Spontaneous abortion (HP:0005268) | 2.21474837 |
104 | Absent phalangeal crease (HP:0006109) | 2.20685182 |
105 | Esophageal varix (HP:0002040) | 2.19364352 |
106 | Nephritis (HP:0000123) | 2.17959941 |
107 | Symptomatic seizures (HP:0011145) | 2.17855138 |
108 | EMG: neuropathic changes (HP:0003445) | 2.14059330 |
109 | Malnutrition (HP:0004395) | 2.13450463 |
110 | Bulbar palsy (HP:0001283) | 2.12457458 |
111 | Hyperactive renin-angiotensin system (HP:0000841) | 2.12154788 |
112 | Abnormality of T cell number (HP:0011839) | 2.11355162 |
113 | Rhabdomyolysis (HP:0003201) | 2.10303111 |
114 | Decreased circulating renin level (HP:0003351) | 2.08686565 |
115 | Vomiting (HP:0002013) | 2.08364980 |
116 | Acanthocytosis (HP:0001927) | 2.07393194 |
117 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.06938482 |
118 | Areflexia of lower limbs (HP:0002522) | 2.05489849 |
119 | Heart block (HP:0012722) | 2.04120703 |
120 | Renal cortical cysts (HP:0000803) | 2.03735818 |
121 | Cardiovascular calcification (HP:0011915) | 2.02715024 |
122 | Abnormality of potassium homeostasis (HP:0011042) | 2.02152389 |
123 | Hypochromic microcytic anemia (HP:0004840) | 2.00831065 |
124 | Irritability (HP:0000737) | 2.00410318 |
125 | Alkalosis (HP:0001948) | 2.00276954 |
126 | Proximal tubulopathy (HP:0000114) | 1.99670767 |
127 | Rhinitis (HP:0012384) | 1.99400855 |
128 | Absent/shortened dynein arms (HP:0200106) | 1.98429912 |
129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.98429912 |
130 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97203412 |
131 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97203412 |
132 | Spastic diplegia (HP:0001264) | 1.96677030 |
133 | Severe combined immunodeficiency (HP:0004430) | 1.92123531 |
134 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90838073 |
135 | Hypokalemia (HP:0002900) | 1.90505488 |
136 | Generalized muscle weakness (HP:0003324) | 1.89874734 |
137 | Systemic lupus erythematosus (HP:0002725) | 1.89528499 |
138 | Abnormal cartilage morphology (HP:0002763) | 1.87804884 |
139 | Abnormal atrioventricular conduction (HP:0005150) | 1.87472019 |
140 | Menorrhagia (HP:0000132) | 1.87318169 |
141 | Mitral stenosis (HP:0001718) | 1.87124816 |
142 | Thrombophlebitis (HP:0004418) | 1.85152290 |
143 | Abnormal ciliary motility (HP:0012262) | 1.84598312 |
144 | Abnormality of the gallbladder (HP:0005264) | 1.83301363 |
145 | Dilated cardiomyopathy (HP:0001644) | 1.83150768 |
146 | Acute hepatic failure (HP:0006554) | 1.83081263 |
147 | Popliteal pterygium (HP:0009756) | 1.82480525 |
148 | Enlarged kidneys (HP:0000105) | 1.82250966 |
149 | Right ventricular cardiomyopathy (HP:0011663) | 1.80984725 |
150 | B lymphocytopenia (HP:0010976) | 1.80100879 |
151 | Abnormality of B cell number (HP:0010975) | 1.80100879 |
152 | Proximal amyotrophy (HP:0007126) | 1.80062331 |
153 | Ventricular tachycardia (HP:0004756) | 1.79546233 |
154 | Gingival bleeding (HP:0000225) | 1.79522421 |
155 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.78721857 |
156 | Cholecystitis (HP:0001082) | 1.78147762 |
157 | Abnormal gallbladder physiology (HP:0012438) | 1.78147762 |
158 | Abnormality of urine glucose concentration (HP:0011016) | 1.77834003 |
159 | Glycosuria (HP:0003076) | 1.77834003 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.97641547 |
2 | SIK1 | 3.56083054 |
3 | FGFR4 | 3.24004697 |
4 | ERN1 | 3.20538647 |
5 | TAOK3 | 3.13120639 |
6 | MAP3K7 | 3.09183452 |
7 | TRIB3 | 3.05285238 |
8 | PKN2 | 2.95706535 |
9 | INSRR | 2.80044788 |
10 | MUSK | 2.51341247 |
11 | PIK3CA | 2.15712051 |
12 | TXK | 1.89138118 |
13 | NUAK1 | 1.87171038 |
14 | PTK6 | 1.77647495 |
15 | OBSCN | 1.77048047 |
16 | PIK3CG | 1.71170773 |
17 | STK38L | 1.66830168 |
18 | TRPM7 | 1.63891246 |
19 | NLK | 1.52641914 |
20 | TTN | 1.51089424 |
21 | MAPK15 | 1.50882105 |
22 | MAP2K3 | 1.44157582 |
23 | DMPK | 1.41251707 |
24 | FLT3 | 1.40165004 |
25 | MST1R | 1.40002649 |
26 | MAPK11 | 1.31869036 |
27 | FRK | 1.30824554 |
28 | TYK2 | 1.30444503 |
29 | EPHA2 | 1.28661119 |
30 | EPHB1 | 1.19880961 |
31 | MAP2K4 | 1.18373840 |
32 | ZAP70 | 1.15440481 |
33 | IRAK3 | 1.14808437 |
34 | MAP4K1 | 1.14250521 |
35 | JAK1 | 1.11888314 |
36 | ERBB4 | 1.09651182 |
37 | JAK2 | 1.07216125 |
38 | NEK9 | 1.05805751 |
39 | LATS1 | 1.02812640 |
40 | TEC | 1.02641822 |
41 | PHKG1 | 1.02038179 |
42 | PHKG2 | 1.02038179 |
43 | GRK6 | 1.00318415 |
44 | PRKAA2 | 1.00252832 |
45 | EPHA3 | 0.98818454 |
46 | ITK | 0.98344328 |
47 | FGFR3 | 0.96828243 |
48 | TBK1 | 0.95217183 |
49 | PINK1 | 0.94927509 |
50 | MAPK12 | 0.92483253 |
51 | MAP3K3 | 0.91533281 |
52 | MAP2K2 | 0.88842861 |
53 | PDK3 | 0.88826045 |
54 | PDK4 | 0.88826045 |
55 | MAP3K10 | 0.88656740 |
56 | CSK | 0.84394405 |
57 | TNK2 | 0.80618635 |
58 | RIPK1 | 0.78732968 |
59 | PDGFRB | 0.78462077 |
60 | DYRK1B | 0.77024344 |
61 | MAP2K6 | 0.76830258 |
62 | FER | 0.76417200 |
63 | CDK6 | 0.75299327 |
64 | PRKCQ | 0.73787669 |
65 | MAPK4 | 0.72105542 |
66 | MAPK7 | 0.70992987 |
67 | MAP3K14 | 0.70116579 |
68 | PRKAA1 | 0.69302280 |
69 | ACVR1B | 0.69149223 |
70 | KDR | 0.68933704 |
71 | SGK3 | 0.68777714 |
72 | AKT3 | 0.67894486 |
73 | FGFR2 | 0.67004085 |
74 | MST4 | 0.64992491 |
75 | IKBKE | 0.62067059 |
76 | MAP3K1 | 0.61386130 |
77 | ERBB2 | 0.61216366 |
78 | RET | 0.60906591 |
79 | CAMK1D | 0.60121068 |
80 | PDPK1 | 0.59814654 |
81 | CDC42BPA | 0.59403004 |
82 | EEF2K | 0.58782110 |
83 | MAPKAPK3 | 0.56650492 |
84 | STK38 | 0.54372270 |
85 | TAOK1 | 0.53902446 |
86 | PDK1 | 0.53689764 |
87 | GSK3A | 0.53533020 |
88 | TIE1 | 0.52067501 |
89 | MARK2 | 0.51544826 |
90 | CDK4 | 0.51343282 |
91 | MAP3K2 | 0.50671180 |
92 | LRRK2 | 0.50261602 |
93 | DAPK2 | 0.49951295 |
94 | CAMK4 | 0.49051407 |
95 | STK39 | 0.48199548 |
96 | WNK4 | 0.47793752 |
97 | MTOR | 0.44795812 |
98 | PRKG1 | 0.44698963 |
99 | MAP3K13 | 0.43492643 |
100 | ICK | 0.43193421 |
101 | PRKACG | 0.43105497 |
102 | TGFBR2 | 0.43023295 |
103 | PRKD1 | 0.42945147 |
104 | NEK6 | 0.41832187 |
105 | JAK3 | 0.40545868 |
106 | ERBB3 | 0.40139941 |
107 | PRKACA | 0.39402670 |
108 | MYLK | 0.39364694 |
109 | LMTK2 | 0.38915965 |
110 | PRKCH | 0.37409822 |
111 | SYK | 0.36224164 |
112 | MAP2K1 | 0.35423672 |
113 | CAMK2G | 0.35159578 |
114 | MAP3K11 | 0.35119931 |
115 | RPS6KA2 | 0.34949836 |
116 | SGK223 | 0.34704604 |
117 | SGK494 | 0.34704604 |
118 | SGK2 | 0.34549212 |
119 | PDK2 | 0.34424140 |
120 | BTK | 0.34106069 |
121 | CAMK1G | 0.33924228 |
122 | NME1 | 0.33693044 |
123 | MAP3K6 | 0.33649957 |
124 | BLK | 0.32576398 |
125 | RPS6KB1 | 0.31747031 |
126 | SGK1 | 0.30808976 |
127 | AKT2 | 0.30649455 |
128 | PRKD3 | 0.30501739 |
129 | TESK2 | 0.29922904 |
130 | OXSR1 | 0.29323181 |
131 | CAMK2D | 0.28123833 |
132 | HCK | 0.27637612 |
133 | MAPK3 | 0.26392592 |
134 | IKBKB | 0.25574746 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03815039 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31307961 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26952742 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.22968210 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.85182678 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84146686 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72969961 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68730179 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55448124 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41337578 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34718737 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33221582 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30651858 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25489464 |
15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15313726 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00475658 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.00157737 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96239686 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91814163 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82372232 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73522371 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73060308 |
23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72901536 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69973782 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68553961 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68055745 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65975684 |
28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59542310 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59203182 |
30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56402191 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56355241 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54427106 |
33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53753275 |
34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51923890 |
35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.51545370 |
36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50393877 |
37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47805874 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47081542 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45358496 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.44618470 |
41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44482155 |
42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39589522 |
43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34338736 |
44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24903671 |
45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21541512 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17432242 |
47 | ABC transporters_Homo sapiens_hsa02010 | 1.16273802 |
48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12455024 |
49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06466527 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05951626 |
51 | Lysine degradation_Homo sapiens_hsa00310 | 1.05120738 |
52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99379452 |
53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92680009 |
54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92515696 |
55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91009549 |
56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90066385 |
57 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89329373 |
58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85584497 |
59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81485533 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81419424 |
61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76279786 |
62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75062960 |
63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72719638 |
64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72582975 |
65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66186685 |
66 | Insulin resistance_Homo sapiens_hsa04931 | 0.60355762 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56894784 |
68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53610905 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53413551 |
70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52988011 |
71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46890540 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44485540 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.42668569 |
74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41772501 |
75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39684914 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39349162 |
77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38364383 |
78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35994002 |
79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35892020 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35578443 |
81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34313519 |
82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33331846 |
83 | Pertussis_Homo sapiens_hsa05133 | 0.32667978 |
84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32027358 |
85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30595014 |
86 | Renin secretion_Homo sapiens_hsa04924 | 0.28344922 |
87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25788458 |
88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25295057 |
89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23867050 |
90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23822522 |
91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19015278 |
92 | Insulin secretion_Homo sapiens_hsa04911 | 0.17765678 |
93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16806487 |
94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16400753 |
95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.16064798 |
96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.15365853 |
97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.14432232 |
98 | Prion diseases_Homo sapiens_hsa05020 | 0.12413196 |
99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.11239989 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10680483 |
101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.08819203 |
102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.07543220 |
103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.07260387 |
104 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.03192347 |
105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.00608520 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.1506162 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1476747 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1405122 |
109 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1359467 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.1357517 |
111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1310491 |
112 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | -0.1092473 |
113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1034237 |
114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0818172 |
115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0638104 |
116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0537617 |
117 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0452645 |
118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0418397 |
119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0249457 |
120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0013395 |
121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0001113 |